Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennon Regulatory News (PNN)

Share Price Information for Pennon (PNN)

Share Price is delayed by 15 minutes
Get Live Data
513.00    9.50 (1.89%)
Bid:
509.00
Ask:
509.50
Spread: 0.50 (0.098%)
Market Cap: £2.42b
PNN Live PriceLast checked at - London Stock Exchange

Intraday Pennon Share Chart

Board Changes

8 Apr 2025 07:00

RNS Number : 0089E
Pennon Group PLC
08 April 2025
 

The Board of Pennon Group Plc (the "Company") is pleased to announce that Andrea Blance has been appointed as a Non-Executive Director and Chair of the Remuneration Committee of the Company with effect from 8 April 2025. 

Andrea brings extensive risk and regulation expertise and is passionate about developing customer focused commercial strategies, following a long career in Financial Services. She is a Non-Executive Director and Risk Committee Chair at Aviva plc and an Advisory Board Member of The Mentoring Foundation.

Andrea spent her executive career at Legal & General Group plc where she held a range of senior leadership roles including Group Chief Risk Officer and Strategy & Marketing Director. More recently, Andrea has been Risk Committee Chair at Hargreaves Lansdown plc, Senior Independent Director and Remuneration Committee Chair of Vanquis Banking Group plc, Senior Independent Director and Audit Committee Chair of ReAssure plc, and Risk Committee Chair of Scottish Widows plc and Lloyds Banking Group Insurance.

Commenting on the appointment, David Sproul, Chair, said, "On behalf of the entire Board, I look forward to welcoming Andrea to Pennon. Her extensive regulatory experience and strong belief in the positive role that businesses should play delivering for customers and communities, and driving sustainable shareholder value, will be invaluable."

Andrea said, "I am absolutely delighted to have been appointed as Remuneration Chair of Pennon. I look forward to working with the Board and a brilliant team of valued colleagues as we look to deliver for customers and all stakeholders, with an enduring positive impact on the environment and society."

The Company confirms that there is no other information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to these appointments.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUBAKRVKUSRAR
Date   Source Headline
3rd Jun 20247:00 amRNSTotal Voting Rights
28th May 20249:03 amRNSDirector Declaration
21st May 20249:51 amRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFull Year Results 2023/24
3rd May 20247:18 amRNSSutton and East Surrey Water - Acquisition update
1st May 20247:00 amRNSTotal Voting Rights
25th Apr 20243:57 pmRNSHolding(s) in Company
22nd Apr 20242:09 pmRNSDirector/PDMR Shareholding
10th Apr 202411:38 amRNSHolding(s) in Company
2nd Apr 20247:00 amRNSTotal Voting Rights
25th Mar 20247:00 amRNSTRADING STATEMENT
21st Mar 20243:11 pmRNSDirector/PDMR Shareholding
5th Mar 20242:46 pmRNSChange of Auditor
1st Mar 20241:22 pmRNSDirector Declaration
1st Mar 20247:00 amRNSTotal Voting Rights
20th Feb 20242:48 pmRNSDirector/PDMR Shareholding
8th Feb 202412:14 pmRNSDirector/PDMR Shareholding
1st Feb 20249:20 amRNSBlock listing Interim Review
1st Feb 20249:12 amRNSTotal Voting Rights
22nd Jan 20243:20 pmRNSDirector/PDMR Shareholding
15th Jan 202411:19 amRNSHolding(s) in Company
12th Jan 20245:05 pmRNSHolding(s) in Company
12th Jan 20242:51 pmRNSDirector/PDMR Shareholding
12th Jan 202410:43 amRNSHolding(s) in Company
11th Jan 202412:08 pmRNSHolding(s) in Company
10th Jan 20244:14 pmRNSRESULTS OF EQUITY CAPITAL RAISE
10th Jan 20247:02 amRNSRetail Offer by PrimaryBid
10th Jan 20247:01 amRNSPROPOSED EQUITY CAPITAL RAISE
10th Jan 20247:00 amRNSPENNON ACQUISITION OF SES WATER
2nd Jan 20247:00 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSDirector/PDMR Shareholding
1st Dec 20237:00 amRNSTotal Voting Rights
29th Nov 20237:00 amRNSHalf Year Results 2023/24
27th Nov 20239:30 amRNSChief Financial Officer Succession
21st Nov 20234:44 pmRNSDirector/PDMR Shareholding
10th Nov 20233:43 pmRNSHolding(s) in Company
1st Nov 20238:58 amRNSTotal Voting Rights
24th Oct 202311:50 amRNSHolding(s) in Company
23rd Oct 20237:00 amRNSDirector/PDMR Shareholding
2nd Oct 20237:00 amRNSTRADING STATEMENT AND BUSINESS PLAN UPDATE
2nd Oct 20237:00 amRNSTotal Voting Rights
20th Sep 20232:35 pmRNSDirector/PDMR Shareholding
13th Sep 20231:39 pmRNSDirector/PDMR Shareholding
1st Sep 20237:00 amRNSBoard Changes
1st Sep 20237:00 amRNSTotal Voting Rights
22nd Aug 20232:43 pmRNSDirector/PDMR Shareholding
7th Aug 20237:00 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSChief Financial Officer Succession
1st Aug 202311:03 amRNSBlock listing Interim Review
1st Aug 202310:59 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.